0001225208-18-001321.txt : 20180119 0001225208-18-001321.hdr.sgml : 20180119 20180119173006 ACCESSION NUMBER: 0001225208-18-001321 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180112 FILED AS OF DATE: 20180119 DATE AS OF CHANGE: 20180119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRADDICK WEIR MIRIAN M CENTRAL INDEX KEY: 0001168014 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 18538292 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4/A 1 doc4a.xml X0306 4/A 2018-01-12 2018-01-16 0000310158 Merck & Co., Inc. MRK 0001168014 GRADDICK WEIR MIRIAN M MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 1 Exe V-P, HR Common Stock 2018-01-12 4 S 0 8000.0000 58.0000 D 98484.3190 D Common Stock 2018-01-16 4 M 0 52000.0000 44.3000 A 150484.3190 D Common Stock 2018-01-16 4 S 0 8000.0000 61.6300 D 142484.3190 D Common Stock 2018-01-16 4 S 0 52000.0000 61.6300 D 90484.3190 D The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan. The original Form 4, filed on January 16, 2018, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 12, 2018 as a total of 5,000 shares sold when in fact 8,000 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 3,000 shares, and includes shares acquired in dividend reinvestment transactions. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. Faye C. Brown as Attorney-in-Fact for Mirian M. Graddick-Weir 2018-01-19